5 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and ... - Canagliflozin ... (Invokana) - Dapagliflozin ... (Farxiga) - Empagliflozin ... (Steglatro) #diabetes
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Diabetes Combination ... Xigduo (metformin + dapagliflozin ... ) • Qtern (dapagliflozin ... Tablets #Oral #DM2 ... Pharmacology #Pills #Endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
gliflozin): • Empagliflozin ... the three • Dapagliflozin ... • Euglycemic diabetic ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
that modulate sodium ... treatment of type II diabetes ... provide significant cardiovascular ... (Invokana®), dapagliflozin ... , #dapagliflozin
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... class of anti-diabetic ... the first one (Canagliflozin ... #Medications #DM2 ... #Diabetes #Endocrinology